Literature DB >> 27573666

Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway.

Millet Treinin1, Roger L Papke2, Eran Nizri3, Tehila Mizrachi4, Talma Brenner4.   

Abstract

BACKGROUND: The nicotinic acetylcholine receptor (nAChR) gene family encodes for subunits of acetylcholine gated ion channels. These receptors are expressed widely and have many functions: They mediate excitation at neuro-muscular junctions. Nicotinic Acetylcholine Receptor: In the central nervous system nAChRs have been implicated in memory, cognition, and addiction. And in non-excitatory cells they regulate differentiation, proliferation and inflammatory responses. The CHRNA7 gene encodes for the α7 nAChR subunit that assembles into a homomeric receptor having unusual properties. It is expressed widely and has many functions atypical for nAChRs; specifically, in immune cells α7 is required for the anti-inflammatory effects of acetylcholine and has been implicated in inflammatory autoimmune diseases including Multiple Sclerosis (MS). Interestingly, although, α7 receptors are found at the outer membranes of immune cells, acetylcholine-dependent currents have not been recorded from these cells. Therefore, its mechanism of action in immune cells needs further evaluation. Maturation of α7 into functional ligand-gated channels in the plasma membrane is a complex process shown to depend on the ER-resident chaperone, RIC-3. Therefore, RIC-3 regulates functional expression of α7. RIC-3 like α7 is expressed in immune cells and has been implicated in MS. Thus, RIC-3 may regulate functional expression of α7 in immune cells.
CONCLUSION: In this review we describe effects and mechanism of action of α7 nAChR and RIC-3 in the immune cholinergic system. Elucidating these mechanisms and the regulation of α7 and RIC-3 in the immune cholinergic system can pave the way for novel immunomodulatory agents, or towards extending the application of cholinergic agents. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cholinergic anti-inflammatory pathway; RIC-3; acetylcholinezzm321990esterase inhibitors; metabotropic cholinergic signaling; multiple sclerosis; α7 nicotinic acetylcholine receptor

Mesh:

Substances:

Year:  2017        PMID: 27573666     DOI: 10.2174/1871524916666160829114533

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  14 in total

Review 1.  Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Authors:  Arianna Crespi; Sara Francesca Colombo; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

2.  GTS-21 Protected Against LPS-Induced Sepsis Myocardial Injury in Mice Through α7nAChR.

Authors:  Weilan Kong; Kai Kang; Yang Gao; Haitao Liu; Xianglin Meng; Yanhui Cao; Songliu Yang; Wen Liu; Jiannan Zhang; Kaijiang Yu; Mingyan Zhao
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

Review 3.  A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.

Authors:  Peter G Shields; Micah Berman; Theodore M Brasky; Jo L Freudenheim; Ewy Mathe; Joseph P McElroy; Min-Ae Song; Mark D Wewers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-22       Impact factor: 4.254

4.  α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.

Authors:  Vanessa Mucchietto; Francesca Fasoli; Susanna Pucci; Milena Moretti; Roberta Benfante; Annalisa Maroli; Simona Di Lascio; Cristiano Bolchi; Marco Pallavicini; Cheryl Dowell; Michael McIntosh; Francesco Clementi; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

5.  Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.

Authors:  Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Marta Quadri; Marco De Amici; Roger L Papke; Clelia Dallanoce
Journal:  Eur J Med Chem       Date:  2020-07-28       Impact factor: 6.514

6.  [Low-intensity pulsed ultrasound pretreatment inhibits HMGB1 expression and attenuates lung ischemia-reperfusion injury in rats via the cholinergic anti-inflammatory pathway].

Authors:  Liangchao Qu; Jinxiu Yan; Zhangjie Jiang; Zhiping Song; Foquan Luo; Qinghua Peng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

7.  Regulation of RIC-3 and of nAChR expression.

Authors:  Yael Ben-David; Millet Treinin
Journal:  Oncotarget       Date:  2017-01-24

Review 8.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

9.  A G protein-coupled α7 nicotinic receptor regulates signaling and TNF-α release in microglia.

Authors:  Justin R King; Trudy C Gillevet; Nadine Kabbani
Journal:  FEBS Open Bio       Date:  2017-08-07       Impact factor: 2.693

10.  Gut-Sourced Vasoactive Intestinal Polypeptide Induced by the Activation of α7 Nicotinic Acetylcholine Receptor Substantially Contributes to the Anti-inflammatory Effect of Sinomenine in Collagen-Induced Arthritis.

Authors:  MengFan Yue; XinYu Zhang; YanNong Dou; ZhiFeng Wei; Yu Tao; YuFeng Xia; Yue Dai
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.